Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

2.

Photocontrollable mononegaviruses.

Tahara M, Takishima Y, Miyamoto S, Nakatsu Y, Someya K, Sato M, Tani K, Takeda M.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11587-11589. doi: 10.1073/pnas.1906531116. Epub 2019 May 28.

3.

Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression.

Nakatsukasa H, Oda M, Yin J, Chikuma S, Ito M, Koga-Iizuka M, Someya K, Kitagawa Y, Ohkura N, Sakaguchi S, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Yamanaka S, Takamura-Enya T, Lu Q, Yoshimura A.

Int Immunol. 2019 Apr 26;31(5):335-347. doi: 10.1093/intimm/dxz008.

PMID:
30726915
4.

Determinants of the Change in Arterial Stiffness in Peritoneal Dialysis Patients.

Nakahigashi M, Tsukaguchi H, Morimoto S, Nakano C, Ueda H, Someya K, Kusabe M, Kikuchi S, Imada T, Shiojima I.

Int Heart J. 2017 Dec 12;58(6):915-925. doi: 10.1536/ihj.16-624. Epub 2017 Nov 17.

5.

Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation.

Someya K, Nakatsukasa H, Ito M, Kondo T, Tateda KI, Akanuma T, Koya I, Sanosaka T, Kohyama J, Tsukada YI, Takamura-Enya T, Yoshimura A.

Int Immunol. 2017 Aug 1;29(8):365-375. doi: 10.1093/intimm/dxx049.

6.

Chronic high-fat feeding impairs adaptive induction of mitochondrial fatty acid combustion-associated proteins in brown adipose tissue of mice.

Ohtomo T, Ino K, Miyashita R, Chigira M, Nakamura M, Someya K, Inaba N, Fujita M, Takagi M, Yamada J.

Biochem Biophys Rep. 2017 Feb 20;10:32-38. doi: 10.1016/j.bbrep.2017.02.002. eCollection 2017 Jul.

7.

Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.

Okada M, Kanamori M, Someya K, Nakatsukasa H, Yoshimura A.

Epigenetics Chromatin. 2017 May 8;10:24. doi: 10.1186/s13072-017-0129-1. eCollection 2017.

8.

A chicken homologue of nectin-4 functions as a measles virus receptor.

Seki F, Someya K, Komase K, Takeda M.

Vaccine. 2016 Jan 2;34(1):7-12. doi: 10.1016/j.vaccine.2015.10.109. Epub 2015 Nov 6.

PMID:
26549360
9.

Erratum for Renal and Vascular Protective Effects of Ezetimibe in Chronic Kidney Disease.

Morita T, Morimoto S, Nakano C, Kubo R, Okuno Y, Seo M, Someya K, Nakahigashi M, Ueda H, Toyoda N, Kusabe M, Jo F, Takahashi N, Iwasaka T, Shiojima I.

Intern Med. 2015;54(13):1683. doi: 10.2169/internalmedicine.54.E002. Epub 2015 Jul 1. No abstract available.

10.

Possible involvement of activated locus coeruleus-noradrenergic neurons in pain-related sleep disorders.

Koh K, Hamada A, Hamada Y, Yanase M, Sakaki M, Someya K, Narita M, Kuzumaki N, Ikegami D, Sakai H, Iseki M, Inada E, Narita M.

Neurosci Lett. 2015 Mar 4;589:200-6. doi: 10.1016/j.neulet.2014.12.002. Epub 2014 Dec 3.

PMID:
25481765
11.

The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease.

Nakano C, Morimoto S, Nakahigashi M, Kusabe M, Ueda H, Someya K, Ichihara A, Iwasaka T, Shiojima I.

Hypertens Res. 2015 Mar;38(3):193-8. doi: 10.1038/hr.2014.163. Epub 2014 Dec 4.

PMID:
25471235
12.

Press-through package mis-swallowing: Usefulness of computed tomography.

Kanazawa A, Kamezaki F, Kido T, Yamasaki S, Someya K, Takama T, Otsubo H, Yoshikawa I, Kamochi M, Mayumi T.

Acute Med Surg. 2014 Nov 7;2(3):195-198. doi: 10.1002/ams2.90. eCollection 2015 Jul.

13.

Peritoneopericardial communication after aortic valve replacement in a peritoneal dialysis patient.

Morimoto S, Nakano C, Someya K, Nakahigashi M, Ueda H, Kusabe M, Morita T, Ichihara A, Iwasaka T.

CEN Case Rep. 2014 Nov;3(2):223-225. doi: 10.1007/s13730-014-0125-2. Epub 2014 Jun 4.

14.

Regulation of regulatory T cells: epigenetics and plasticity.

Okada M, Hibino S, Someya K, Yoshmura A.

Adv Immunol. 2014;124:249-73. doi: 10.1016/B978-0-12-800147-9.00008-X. Review.

PMID:
25175778
15.

Loss of Sprouty4 in T cells ameliorates experimental autoimmune encephalomyelitis in mice by negatively regulating IL-1β receptor expression.

Fukaya T, Someya K, Hibino S, Okada M, Yamane H, Taniguchi K, Yoshimura A.

Biochem Biophys Res Commun. 2014 May 9;447(3):471-8. doi: 10.1016/j.bbrc.2014.04.012. Epub 2014 Apr 13.

PMID:
24732356
16.

Renal and vascular protective effects of ezetimibe in chronic kidney disease.

Morita T, Morimoto S, Nakano C, Kubo R, Okuno Y, Seo M, Someya K, Nakahigashi M, Ueda H, Toyoda N, Kusabe M, Jo F, Takahashi N, Iwasaka T, Shiojima I.

Intern Med. 2014;53(4):307-14. Erratum in: Intern Med. 2015;54(13):1683.

17.

Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis.

Mayumi T, Someya K, Ootubo H, Takama T, Kido T, Kamezaki F, Yoshida M, Takada T.

J UOEH. 2013 Dec 1;35(4):249-57.

18.

Selective androgen receptor modulator, YK11, regulates myogenic differentiation of C2C12 myoblasts by follistatin expression.

Kanno Y, Ota R, Someya K, Kusakabe T, Kato K, Inouye Y.

Biol Pharm Bull. 2013;36(9):1460-5.

19.

New micro forceps with high utility for various uses in microincision vitrectomy surgery.

Enaida H, Kadonosono K, Emi K, Inoue M, Someya K, Ishibashi T.

Retina. 2013 Jan;33(1):244-6. doi: 10.1097/IAE.0b013e31827b657d. No abstract available.

PMID:
23222464
20.

Clonal growth of carp (Cyprinus carpio) T cells in vitro: long-term proliferation of Th2-like cells.

Yamaguchi T, Katakura F, Someya K, Dijkstra JM, Moritomo T, Nakanishi T.

Fish Shellfish Immunol. 2013 Feb;34(2):433-42. doi: 10.1016/j.fsi.2012.11.005. Epub 2012 Nov 24.

PMID:
23182723
21.

Fluorescence polarization-based assay using N-glycan-conjugated quantum dots for screening in hemagglutinin blockers for influenza A viruses.

Okamatsu M, Feng F, Ohyanagi T, Nagahori N, Someya K, Sakoda Y, Miura N, Nishimura S, Kida H.

J Virol Methods. 2013 Feb;187(2):390-4. doi: 10.1016/j.jviromet.2012.11.004. Epub 2012 Nov 16.

22.

Olmesartan induces renoprotective effects by stimulating angiotensin type 2 receptors and reducing oxidative stress in diabetic nephropathy.

Jo F, Morimoto S, Nakahigashi M, Kusabe M, Someya K, Morita T, Jo H, Imada T, Kosaki A, Toyoda N, Nishikawa M, Iwasaka T.

Kidney Blood Press Res. 2011;34(6):418-23. doi: 10.1159/000328330. Epub 2011 Jun 28.

23.

A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis.

Morimoto S, Nakajima F, Morita T, Someya K, Kusabe M, Nakahigashi M, Yurugi T, Fukui M, Okamoto T, Jo F, Toyoda N, Iwasaka T.

Clin Exp Nephrol. 2011 Jun;15(3):419-423. doi: 10.1007/s10157-011-0407-3. Epub 2011 Feb 18.

PMID:
21331743
24.

Characteristics of 20-year survivors undergoing maintenance hemodialysis.

Morimoto S, Nishioka H, Morita T, Jo F, Someya K, Nakahigashi M, Kusabe M, Ueda H, Takahashi N, Iwasaka T, Maki K.

Ther Apher Dial. 2010 Dec;14(6):547-51. doi: 10.1111/j.1744-9987.2010.00846.x.

PMID:
21118361
25.

Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.

Morimoto S, Kido E, Higashi M, Sumitani N, Takagishi H, Kakimoto S, Someya K, Morita T, Iwasaka T, Suzuki K, Yasui A.

Clin Nephrol. 2010 Dec;74(6):491-2. No abstract available.

PMID:
21084055
26.

Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients.

Takahashi N, Morimoto S, Okigaki M, Seo M, Someya K, Morita T, Matsubara H, Sugiura T, Iwasaka T.

Nephrol Dial Transplant. 2011 Apr;26(4):1252-7. doi: 10.1093/ndt/gfq547. Epub 2010 Sep 3.

PMID:
20817670
27.

Intradermal delivery of recombinant vaccinia virus vector DIs induces gut-mucosal immunity.

Yoshino N, Kanekiyo M, Hagiwara Y, Okamura T, Someya K, Matsuo K, Ami Y, Sato S, Yamamoto N, Honda M.

Scand J Immunol. 2010 Aug;72(2):98-105. doi: 10.1111/j.1365-3083.2010.02416.x.

28.

Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis.

Takeshita H, Watanabe J, Kimura Y, Kawakami K, Takahashi H, Takemura M, Kitamura A, Someya K, Nakajima R.

Bioorg Med Chem Lett. 2010 Jul 1;20(13):3893-6. doi: 10.1016/j.bmcl.2010.05.024. Epub 2010 May 15.

PMID:
20605446
29.

Polyprenylated benzoylphloroglucinol-type derivatives including novel cage compounds from Hypericum erectum.

Ishida Y, Shirota O, Sekita S, Someya K, Tokita F, Nakane T, Kuroyanagi M.

Chem Pharm Bull (Tokyo). 2010 Mar;58(3):336-43.

30.

A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis.

Morimoto S, Takahashi N, Someya K, Morita T, Jo F, Toyoda N, Kosaki A, Nishikawa M, Iwasaka T.

Clin Exp Nephrol. 2010 Aug;14(4):363-6. doi: 10.1007/s10157-010-0271-6. Epub 2010 Feb 26.

PMID:
20186457
31.

In vitro antifungal activities of D11-2040, a beta-1,6-glucan inhibitor, with or without currently available antifungal drugs.

Kitamura A, Someya K, Okumura R, Hata M, Takeshita H, Nakajima R.

Biol Pharm Bull. 2010;33(2):192-7.

32.

Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals.

Morimoto S, Takahashi N, Morita T, Someya K, Toyoda N, Iwasaka T.

Integr Blood Press Control. 2010;3:73-9. Epub 2010 Jun 3.

33.

Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.

Murakami T, Eda Y, Nakasone T, Ami Y, Someya K, Yoshino N, Kaizu M, Izumi Y, Matsui H, Shinohara K, Yamamoto N, Honda M.

AIDS. 2009 Jul 31;23(12):1485-94. doi: 10.1097/QAD.0b013e32832e5331.

PMID:
19528788
34.

Experimental evaluation of a new antithrombogenic stent using ion beam surface modification.

Sugita Y, Suzuki Y, Someya K, Ogawa A, Furuhata H, Miyoshi S, Motomura T, Miyamoto H, Igo S, Nosé Y.

Artif Organs. 2009 Jun;33(6):456-63. doi: 10.1111/j.1525-1594.2009.00747.x.

PMID:
19473141
35.

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer.

Onuki M, Matsumoto K, Satoh T, Oki A, Okada S, Minaguchi T, Ochi H, Nakao S, Someya K, Yamada N, Hamada H, Yoshikawa H.

Cancer Sci. 2009 Jul;100(7):1312-6. doi: 10.1111/j.1349-7006.2009.01161.x. Epub 2009 Apr 22.

36.

Discovery of a small-molecule inhibitor of {beta}-1,6-glucan synthesis.

Kitamura A, Someya K, Hata M, Nakajima R, Takemura M.

Antimicrob Agents Chemother. 2009 Feb;53(2):670-7. doi: 10.1128/AAC.00844-08. Epub 2008 Nov 17.

37.

Mucosal administration of completely non-replicative vaccinia virus recombinant Dairen I strain elicits effective mucosal and systemic immunity.

Yoshino N, Kanekiyo M, Hagiwara Y, Okamura T, Someya K, Matsuo K, Ami Y, Sato S, Yamamoto N, Honda M.

Scand J Immunol. 2008 Nov;68(5):476-83. doi: 10.1111/j.1365-3083.2008.02168.x. Epub 2008 Sep 18.

38.

The suppressive effect of apricot kernel extract on 5alpha-Androst-16-en-3-one generated by microbial metabolism.

Mikoshiba S, Takenaka H, Okumura T, Someya K, Ohdera M.

Int J Cosmet Sci. 2006 Feb;28(1):45-52. doi: 10.1111/j.1467-2494.2006.00297.x.

PMID:
18492200
39.

Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists.

Mori A, Ogawa K, Someya K, Kunori Y, Nagakubo D, Yoshie O, Kitamura F, Hiroi T, Kaminuma O.

Int Immunol. 2007 Aug;19(8):913-21.

PMID:
17804691
40.

Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.

Someya K, Xin KQ, Ami Y, Izumi Y, Mizuguchi H, Ohta S, Yamamoto N, Honda M, Okuda K.

Virology. 2007 Oct 25;367(2):390-7. Epub 2007 Jul 12.

41.

In situ gas generation for micro gas analysis system.

Ohira S, Someya K, Toda K.

Anal Chim Acta. 2007 Apr 4;588(1):147-52. Epub 2007 Feb 4.

PMID:
17386804
42.

Cryptides: functional cryptic peptides hidden in protein structures.

Ueki N, Someya K, Matsuo Y, Wakamatsu K, Mukai H.

Biopolymers. 2007;88(2):190-8.

PMID:
17245751
43.
44.

Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection.

Eda Y, Murakami T, Ami Y, Nakasone T, Takizawa M, Someya K, Kaizu M, Izumi Y, Yoshino N, Matsushita S, Higuchi H, Matsui H, Shinohara K, Takeuchi H, Koyanagi Y, Yamamoto N, Honda M.

J Virol. 2006 Jun;80(11):5563-70.

45.

Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol.

Someya K, Ami Y, Nakasone T, Izumi Y, Matsuo K, Horibata S, Xin KQ, Yamamoto H, Okuda K, Yamamoto N, Honda M.

J Immunol. 2006 Feb 1;176(3):1784-95.

46.

Avian flu: isolation of drug-resistant H5N1 virus.

Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y.

Nature. 2005 Oct 20;437(7062):1108. Erratum in: Nature. 2005 Dec 8;438(7069):754.

PMID:
16228009
47.

Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.

Ami Y, Izumi Y, Matsuo K, Someya K, Kanekiyo M, Horibata S, Yoshino N, Sakai K, Shinohara K, Matsumoto S, Yamada T, Yamazaki S, Yamamoto N, Honda M.

J Virol. 2005 Oct;79(20):12871-9. Erratum in: J Virol. 2006 Oct;80(20):10288.

48.

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.

Xin KQ, Jounai N, Someya K, Honma K, Mizuguchi H, Naganawa S, Kitamura K, Hayakawa T, Saha S, Takeshita F, Okuda K, Honda M, Klinman DM, Okuda K.

Gene Ther. 2005 Dec;12(24):1769-77.

PMID:
16079886
49.
50.

Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.

Someya K, Cecilia D, Ami Y, Nakasone T, Matsuo K, Burda S, Yamamoto H, Yoshino N, Kaizu M, Ando S, Okuda K, Zolla-Pazner S, Yamazaki S, Yamamoto N, Honda M.

J Virol. 2005 Feb;79(3):1452-62.

Supplemental Content

Loading ...
Support Center